Trial Profile
Efficacy and safety of FYX-051 compared with allopurinol in Patients with Hyperuricemia (with or without Gout)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Topiroxostat (Primary) ; Allopurinol
- Indications Hyperuricaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanwa Kagaku Kenkyusho
- 26 Apr 2017 Planned number of patients changed to 200.
- 31 May 2016 New trial record